Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum 22nd Century Group Inc XXII

22nd Century Group, Inc. is an agricultural biotechnology company. The Company is focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. Additionally, the Company provide contract manufacturing services for conventional combustible tobacco products for third-party brands. The Company operates through a single segment named Tobacco... see more

NDAQ:XXII - Post Discussion

22nd Century Group Inc > $XXII: Pioneering the Future of Tobacco
View:
Post by khandaanita4444 on Sep 26, 2024 1:57pm

$XXII: Pioneering the Future of Tobacco

In a strategic move earlier this year, 22nd Century Group, Inc. (NASDAQ: $XXII) entered into an agreement with a key customer for its export conventional cigarette products business. This deal is set to boost the company's contract manufacturing volumes by an impressive 20%, signaling a significant expansion in its operational capacity.

Production under this new agreement has begun to steadily ramp up, positioning 22nd Century for increased output throughout the remainder of 2024. As the company's manufacturing capabilities continue to grow, 2025 is expected to see even more substantial increases in production volumes, supporting 22nd Century's broader goals in the nicotine industry.

The agreement aligns with 22nd Century’s strategic focus on diversifying its product offerings and penetrating international markets, particularly in the export sector. This initiative comes as part of a broader effort to strengthen the company’s revenue streams while expanding its market reach.

As the partnership matures and production continues to rise, 22nd Century Group’s contract manufacturing business is poised for robust growth, potentially making it a key driver of the company's long-term profitability and positioning it as a significant player in the global tobacco market.

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities